Trial
NCT03061708
Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Samsung Medical Center
Collaborators
—
Condition
Stomach Neoplasms
Intervention
AZD2014
Why stopped
lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-20